Tuesday 13 October 2026
Export SLSN’s income statement to Excel — free account
Solesence, Inc.
SLSN Consumer Defensive Household & Personal Products
Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.02
0.00
0.00%
Follow SLSN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
211.84 | 82.90 | 115.85 | 0.00 |
P/S ratio |
3.65 | 1.81 | 1.11 | 0.94 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(90.41) | 61.87 | 44.23 | 273.67 | |
P/B ratio |
13.18 | 7.99 | 3.95 | 3.97 | |
Price to Tangible BV |
13.18 | 7.99 | 3.95 | 3.97 | |
EV/Sales |
3.83 | 2.04 | 1.33 | 1.37 | |
EV/EBITDA |
90.49 | 51.25 | 44.58 | 0.00 | |
EV/Operating CF |
(29.05) | (14.77) | 468.23 | 74.82 | |
EV/FCF |
(19.07) | (11.81) | (30.41) | (89.53) | |
Quick Ratio |
0.57 | 0.58 | 0.55 | 0.40 | |
Current Ratio |
1.84 | 1.81 | 2.08 | 0.97 | |
Net Debt/EBITDA |
(18.11) | (88.47) | (67.93) | 29.82 | |
Debt/Assets |
19.45% | 32.83% | 28.34% | 30.77% | |
Debt/Equity |
0.61 | 1.08 | 0.80 | 1.09 | |
Asset Turnover |
1.22 | 1.29 | 1.15 | 1.04 | |
Operating CF/Net income |
2.24 | (4.51) | (1.98) | (1.21) | |
Capex/Depreciation |
(1.86) | (2.04) | (1.69) | (1.45) | |
Interest Coverage |
(2.30) | (1.15) | (1.92) | 0.43 | |
Research and Development Expense of Revenue |
7.41% | 8.29% | 8.04% | 6.18% | |
Selling, General and Administrative Expense of Revenue |
21.02% | 17.72% | 21.60% | 24.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.84% | 1.65% | 0.64% | 0.52% | |
Graham Net Nets |
(0.02) | (0.06) | (0.07) | (0.15) | |
Graham Number |
0.29 | 0.29 | 0.21 | 0.00 | |
Earnings Yield |
0.47% | 1.21% | 0.86% | (4.59%) | |
Free Cash Flow Yield |
(5.50%) | (9.52%) | (3.92%) | (1.62%) | |
Revenue per Share |
0.21 | 0.18 | 0.18 | 0.22 | |
Operating CF per Share |
(0.04) | 0.03 | 0.02 | 0.00 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.04) | 0.02 | 0.01 | 0.00 | |
Cash per Share |
0.01 | 0.02 | 0.01 | 0.01 | |
Shareholders Equity per Share |
0.24 | 0.20 | 0.24 | 0.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.24 | 0.20 | 0.24 | 0.19 | |
Free Cash Flow |
(2.93) | 1.37 | 0.99 | (0.28) | |
Working Capital |
14.93 | 11.30 | 13.72 | (0.74) | |
Capital Expenditures |
(0.42) | (0.45) | (0.53) | (0.47) | |
Net Current Asset Value |
(3.97) | (7.19) | (4.41) | (8.01) | |
EV/EBIT |
137.86 | 80.49 | 98.61 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | |
Price to Operating Income |
131.45 | 71.60 | 82.63 | 0.00 | |
| Other line items | |||||
Average Receivables |
9.22 | 5.85 | 7.73 | 10.20 | |
Average Payables |
5.69 | 6.60 | 6.92 | 5.93 | |
Average Inventory |
16.96 | 17.62 | 19.74 | 16.39 | |
Average Assets |
51.02 | 48.25 | 52.41 | 53.20 | |
Average Common Equity |
16.20 | 14.52 | 16.06 | 15.67 |
Columns are period end dates